Welcome to our dedicated page for Jfrog SEC filings (Ticker: FROG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking the financial heartbeat of a DevOps pioneer isn’t easy. FROG’s filings dive deep into subscription economics, cloud-migration metrics and security vulnerability risks—data points that rarely fit neatly into a quick headline. If navigating a 300-page 10-K to find how Artifactory or Xray drives recurring revenue feels daunting, you’re not alone.
Stock Titan solves that problem. Our AI reads every word the moment a document lands on EDGAR, then highlights what matters: deferred revenue trends in the latest FROG quarterly earnings report 10-Q filing, newly disclosed vulnerabilities in an 8-K, or dilution impact buried in the proxy statement. Interactive summaries answer the exact questions professionals ask—“How is cloud ARR growing?” or “What triggers FROG’s executive stock awards?”—in seconds.
Every form is covered and continuously refreshed:
- 10-K and 10-Q reports with plain-language breakdowns of R&D spend, customer concentration and cash flow
- FROG insider trading Form 4 transactions streamed in real time, so you see when founders sell or buy
- 8-K material events explained, from critical vulnerability disclosures to strategic partnerships
- Proxy statement executive compensation details contextualised against sector norms
Whether you’re analysing FROG Form 4 insider transactions real-time, comparing pipeline backlog across quarters, or just need the FROG annual report 10-K simplified, our expert-built AI turns dense regulatory text into actionable insight. Spend less time searching and more time deciding.
UBS AG is offering $170,000 in Trigger Autocallable Contingent Yield Notes linked to the common stock of UnitedHealth Group Incorporated (UNH). The three-year notes pay a 10.12% p.a. contingent coupon each quarter only when UNH’s closing price is at or above the Coupon Barrier of $185.13 (60% of the $308.55 Initial Level). If UNH closes at or above the Initial Level on any observation date prior to maturity, the notes are automatically called and investors receive the $10 principal plus the applicable coupon.
If not called, principal is protected at maturity only when the Final Level is at or above the Downside Threshold (also $185.13). Should UNH finish below this threshold, repayment equals $10 × (1 + underlying return), exposing investors to a one-for-one loss that could reach 100% of capital.
- Issue price: $10 per note (minimum purchase 100 notes).
- Estimated initial value: $9.51, reflecting underwriting discount ($0.225 per note) and hedging/issuance costs.
- Observation schedule: Quarterly dates from 6 Oct 2025 through 6 Jul 2028; maturity 10 Jul 2028.
- Credit risk: Unsubordinated, unsecured obligations of UBS AG; payments depend on UBS solvency and are not FDIC-insured.
- Liquidity: Notes will not be listed; secondary market making is at UBS’s discretion and may involve significant bid–ask spreads.
Key risk highlights include potential loss of up to 100% of principal, non-payment of coupons if UNH trades below the barrier, valuation and liquidity uncertainties, conflicts of interest in pricing and hedging, and complex U.S. tax treatment. The product may appeal to investors comfortable with single-stock volatility who seek enhanced income and can tolerate both equity downside and issuer credit exposure.